A new study describes a technique that rejuvenates aging blood-forming stem cells and could help reduce the risk of age-related blood disorders.

Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...

In the study, immune deficient mice were injected with the lab engineered human blood stem cells. It found the blood stem cells became functional bone marrow at similar levels to that seen in ...

Orthopedic non-invasive stem cell therapy regenerates damaged tissue rather than just improving symptoms. Autologous stem cell therapy uses cells from your own body, minimizing rejection risks.

For the better part of a century, modern medicine has operated on a pharmacological model: identify a symptom and suppress it with a chemical. While this approach has saved countless lives, it has ...

Motixafortide alone and in combination with natalizumab (VLA-4 inhibitor) led to robust hematopoietic stem cell (HSC) mobilization predicting 16.9 million and 19.6 million cells/kg collected in a ...

Stem cell therapy offers a minimally invasive alternative to joint replacement surgery, with recovery times of just one to two weeks compared to months for major surgery Clinical studies show varying ...